95 related articles for article (PubMed ID: 14565505)
21. Effect of cell culture conditions on the anticytomegalovirus activity of maribavir.
Chou S; Van Wechel LC; Marousek GI
Antimicrob Agents Chemother; 2006 Jul; 50(7):2557-9. PubMed ID: 16801445
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biological evaluation of tricyclic nucleosides (dimensional probes) as analogues of certain antiviral polyhalogenated benzimidazole ribonucleosides.
Zhu Z; Lippa B; Drach JC; Townsend LB
J Med Chem; 2000 Jun; 43(12):2430-7. PubMed ID: 10882370
[TBL] [Abstract][Full Text] [Related]
23. Ribonucleosides bearing Michael acceptors: synthesis, molecular docking, enzyme inhibition data and antiviral activity.
Nair V; Uchil V; Ma X; Zhu Q; Zhang F; Bonsu E
Nucleic Acids Symp Ser (Oxf); 2008; (52):625-6. PubMed ID: 18776535
[No Abstract] [Full Text] [Related]
24. Antiviral activity of maribavir in combination with other drugs active against human cytomegalovirus.
Chou S; Ercolani RJ; Derakhchan K
Antiviral Res; 2018 Sep; 157():128-133. PubMed ID: 30040968
[TBL] [Abstract][Full Text] [Related]
25. Identification of acetylated, tetrahalogenated benzimidazole D-ribonucleosides with enhanced activity against human cytomegalovirus.
Hwang JS; Kregler O; Schilf R; Bannert N; Drach JC; Townsend LB; Bogner E
J Virol; 2007 Nov; 81(21):11604-11. PubMed ID: 17728228
[TBL] [Abstract][Full Text] [Related]
26. Maribavir (ViroPharma).
Lu H; Thomas S
Curr Opin Investig Drugs; 2004 Aug; 5(8):898-906. PubMed ID: 15600248
[TBL] [Abstract][Full Text] [Related]
27. Conserved domains and structure prediction of human cytomegalovirus UL27 protein.
Hantz S; Couvreux A; Champier G; Trapes L; Cotin S; Denis F; Bouaziz S; Alain S
Antivir Ther; 2009; 14(5):663-72. PubMed ID: 19704169
[TBL] [Abstract][Full Text] [Related]
28. Antiviral activity of 3-(3,5-dimethylbenzyl)uracil derivatives against HIV-1 and HCMV.
Maruyama T; Demizu Y; Kozai S; Witvrouw M; Pannecouque C; Balzarini J; Snoecks R; Andrei G; De Clercq E
Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1553-8. PubMed ID: 18066825
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and antiviral activity of novel 4,5-disubstituted 7-(beta-D-ribofuranosyl)pyrrolo[2,3-d][1,2,3]triazines and the novel 3-amino-5-methyl-1-(beta-D-ribofuranosyl)- and 3-amino-5-methyl-1-(2-deoxy-beta-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,7,8-hexaazaacenaphthylene as analogues of triciribine.
Migawa MT; Drach JC; Townsend LB
J Med Chem; 2005 Jun; 48(11):3840-51. PubMed ID: 15916436
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of action of the ribopyranoside benzimidazole GW275175X against human cytomegalovirus.
Underwood MR; Ferris RG; Selleseth DW; Davis MG; Drach JC; Townsend LB; Biron KK; Boyd FL
Antimicrob Agents Chemother; 2004 May; 48(5):1647-51. PubMed ID: 15105116
[TBL] [Abstract][Full Text] [Related]
31. Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity.
Champier G; Couvreux A; Hantz S; Rametti A; Mazeron MC; Bouaziz S; Denis F; Alain S
Antivir Ther; 2008; 13(5):643-54. PubMed ID: 18771048
[TBL] [Abstract][Full Text] [Related]
32. IMPDH as a biological probe for RNA antiviral drug discovery: synthesis, enzymology, molecular docking, and antiviral activity of new ribonucleosides with surrogate bases.
Nair V; Ma X; Shu Q; Zhang F; Uchil V; Cherukupalli GR
Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):651-4. PubMed ID: 18066873
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antiviral evaluation of isatin ribonucleosides.
de Oliveira MR; Torres JC; Garden SJ; dos Santos CV; Alves TR; Pinto AC; Pereira Hde S; Ferreira LR; Moussatché N; Frugulhetti IC; Ferreira VF; de Souza MC
Nucleosides Nucleotides Nucleic Acids; 2002; 21(11-12):825-35. PubMed ID: 12537024
[TBL] [Abstract][Full Text] [Related]
34. Acyclic sugar analogs of triciribine: lack of antiviral and antiproliferative activity correlate with low intracellular phosphorylation.
Porcari AR; Borysko KZ; Ptak RG; Breitenbach JM; Wotring LL; Drach JC; Townsend LB
Nucleosides Nucleotides; 1999; 18(11-12):2475-97. PubMed ID: 10639750
[TBL] [Abstract][Full Text] [Related]
35. [Ribonucleoside and 2'-deoxyribonucleoside 5'-phosphonates: synthesis and antiviral activity].
Shirokova EA; Ias'ko MV; Shipitsyn AV; Kraevskiĭ AA; Ostrander M; O'Hara B; Baron P; Maclow K; Polsky B
Mol Biol (Mosk); 1994; 28(1):224-32. PubMed ID: 8145753
[TBL] [Abstract][Full Text] [Related]
36. Maribavir and human cytomegalovirus-what happened in the clinical trials and why might the drug have failed?
Marty FM; Boeckh M
Curr Opin Virol; 2011 Dec; 1(6):555-62. PubMed ID: 22440913
[TBL] [Abstract][Full Text] [Related]
37. Benzimidazole analogs inhibit human herpesvirus 6.
Prichard MN; Frederick SL; Daily S; Borysko KZ; Townsend LB; Drach JC; Kern ER
Antimicrob Agents Chemother; 2011 May; 55(5):2442-5. PubMed ID: 21300829
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antiproliferative and antiviral activity of carbohydrate-modified pyrrolo[2,3-d]pyridazin-7-one nucleosides.
Meade EA; Wotring LL; Drach JC; Townsend LB
J Med Chem; 1997 Feb; 40(5):794-801. PubMed ID: 9057866
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationships among 2-substituted 5,6-dichloro-, 4,6-dichloro-, and 4,5-dichloro-1-[(2-hydroxyethoxy) methyl]- and -1-[(1,3-dihydroxy-2-propoxy) methyl]benzimidazoles.
Saluja S; Zou R; Drach JC; Townsend LB
J Med Chem; 1996 Feb; 39(4):881-91. PubMed ID: 8632412
[TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of a potent macrocyclic 1,6-naphthyridine anti-human cytomegalovirus (HCMV) inhibitors.
Falardeau G; Lachance H; St-Pierre A; Yannopoulos CG; Drouin M; Bédard J; Chan L
Bioorg Med Chem Lett; 2005 Mar; 15(6):1693-5. PubMed ID: 15745823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
